TYRA · Forms 3, 4, 5
Insider trades at Tyra Biosciences, Inc.
1 insider bought $20K of Tyra Biosciences, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Tyra Biosciences, Inc. (TYRA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | Options or other derivatives | Form 4 | ||||
| Todd Harris | President and CEO | Award | 864 | $9.13 | $8K | Form 4 | |
| Yuliya Rueb | Vice President, Finance (PAO) | Award | 2,925 | $9.13 | $27K | Form 4 | |
| Alan Fuhrman | Chief Financial Officer | Award | 951 | $9.13 | $9K | Form 4 | |
| Rehan Verjee | Director | Buy | 972 | $20.58 | $20K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.